Top 8 Active Investors in Belgium (2025): Complete Guide to Belgian VC Firms
Belgium punches above its weight in B2B software, deep tech (imec/university spin-outs), and life sciences (Leuven/Ghent clusters)—and in 2025, the best local funds are very much deploying. Belgian VC deal value rose in 2024 (PwC reports a 41% increase vs 2023) and investors surveyed expected deal flow to rise in 2025. (PwC Belgium)
When preparing your pitch to Belgian investors, having a professional data room is essential. Peony helps Belgium startups organize investor materials with AI-powered document organization, track investor engagement with page-level analytics, and securely share sensitive financial and operational data. With transparent pricing at $40/user/month, Peony delivers enterprise-grade secure data rooms without the $5,000-20,000 per-deal costs of legacy platforms.
This guide is a Belgium-only list: Belgium-headquartered funds with strong reputations locally and visible proof of activity (new funds, recent deals, ongoing deployments).
1) How to pick the right Belgian investor (fast, no wasted meetings)
Match the investor to your real stage
- Pre-seed/Seed: you're selling a wedge + speed + early signal.
- Series A / Growth: you're selling repeatability (retention, CAC payback, expansion).
Belgian funds are often quite specialized—trying to "pitch everyone" is the fastest way to die slowly.
Pick by ecosystem path: "SaaS GTM" vs "Deep-tech validation" vs "Life sciences"
Belgium has three dominant investor lanes:
- B2B SaaS / enterprise software (Antwerp/Ghent/Brussels)
- Deep tech / semiconductors / industrial R&D (imec + universities)
- Biotech / medtech / therapeutics (Leuven & Ghent life sciences)
Choose investors whose platform matches your bottleneck: sales motion, clinical validation, lab infrastructure, or partnerships.
Use "fresh dry powder" as a filter
New funds = faster decisions + follow-ons. In 2025 you can literally prioritize firms that just announced a new fund close (examples below: Smartfin and Volta). (Smartfin)
Ask one question that reveals everything
"What does 'success' look like 12 months after you invest?"
If they can't answer crisply (milestones, hiring plan, distribution, validation), they'll be vague partners too.
2) Detailed profiles: 8 top active Belgian investors (2025)
1) Fortino Capital (Antwerp) — B2B software VC + growth equity
Why founders rate them highly: they're one of the clearest "Belgium-to-Europe" platforms for scaling B2B software, and they keep deploying into real SaaS. Fortino describes itself as a leading B2B software VC/PE firm with offices in Antwerp/Amsterdam/Munich. (Fortino Capital)
What they're actively doing (signal):
- Fortino announced in 2025 it has raised €800M+ across funds over time. (Fortino Capital)
- They closed a €377M Private Equity fund (PE II) dedicated to B2B software founders. (Fortino Capital)
- They're still publishing and backing rounds (e.g., 2025 portfolio news). (Fortino Capital)
Stage sweet spot: early growth → growth (and some venture), especially when you have a clear B2B motion.
Best fit if you are: enterprise SaaS, vertical SaaS, B2B infra/tools, and you want a partner who cares about "how to scale" not just "cool tech."
How to pitch Fortino (Belgium angle):
- Show a clean GTM loop: ICP → channel → sales cycle → expansion.
- Bring crisp unit economics (even early): gross margin logic + payback plan.
2) imec.xpand (Leuven) — Belgium's deep-tech superpower
Why they're top-tier: imec.xpand launched a €300M fund to back transformative semiconductor/nanotech innovation—this is one of Belgium's most globally credible deep-tech investor platforms. (imec)
What they're actively doing (signal):
- Official announcement: new €300M fund focused on semiconductors/nanotech innovations (2024 launch). (imec)
Stage sweet spot: early-stage deep tech (with serious R&D), with capacity for follow-ons. (imec)
Best fit if you are: chips, photonics, advanced sensors, nanoelectronics, frontier hardware where imec infrastructure and expertise matter.
How to pitch imec.xpand:
- Make "lab → prototype → manufacturable product" explicit.
- Be honest about timelines and risk retirement (deep tech investors prefer realism to hype).
3) Smartfin (Brussels) — Growth equity for B2B tech scale-ups
Why they're top-tier in 2025: they closed Smartfin Capital III at €250M in January 2025, backed by the European Investment Fund (EIF), to step up investments in Europe's B2B technology scale-ups. (Smartfin)
What they're actively doing (signal):
- €250M Fund III close (Jan 2025) with EIF backing. (Smartfin)
Stage sweet spot: Series A/B+ and growth rounds (when you're scaling distribution).
Best fit if you are: B2B SaaS with meaningful revenue and a scaling plan that needs real capital + discipline.
How to pitch Smartfin:
- Put KPIs front and center: ARR quality, retention, CAC payback, expansion revenue.
- Show the "growth machine" and what breaks at 2–3x scale.
4) Volta Ventures (Ghent) — Seed & early-stage B2B software (fresh 2025 fund)
Why founders like them: they're one of the most founder-aligned early-stage B2B investors in the Benelux, and they're visibly active.
What they're actively doing (signal):
- Volta launched a dedicated (pre-)seed fund in April 2025, aimed at early-stage B2B software startups in the Benelux (targeting ~15 companies). (Volta Ventures)
Stage sweet spot: pre-seed → seed (especially if you're building B2B SaaS).
Best fit if you are: enterprise software with a sharp wedge and early traction (or founder-level credibility + clear buyer pain).
How to pitch Volta:
- Keep it simple: problem, wedge, why you win, first channel.
- Show speed: weekly shipping + tight customer loop.
5) Capricorn Partners (Leuven) — Health + digital + clean tech (new health-tech fund close)
Why they're top-tier: Capricorn is a long-running Belgian investment manager across venture/growth themes and has been active raising/closing sector funds.
What they're actively doing (signal):
- Capricorn Partners secured €51M first close for Capricorn Health-tech Fund II (Jan 2025). (EU-Startups)
- Their own positioning focuses on investing in innovative companies across digital, health, and clean technologies. (Capricorn Partners)
Stage sweet spot: early → growth (varies by vehicle), with strength in health and impact-leaning tech.
Best fit if you are: health-tech (clinical workflow, diagnostics platforms, regulated-ish tech), or tech with a clear impact thesis.
How to pitch Capricorn:
- Bring proof: pilots, validation plan, regulatory/reimbursement stance if relevant.
- Tie outcomes to ROI (cost, throughput, risk reduction).
6) Qbic (Ghent) — Seed VC for university/research spin-offs (active into late 2025)
Why they're top-tier: Qbic is one of Belgium's key "research-to-startup" investors, designed for knowledge-partner spin-offs and deep-tech commercialization.
What they're actively doing (signal):
- Qbic describes itself as a seed and early-stage venture capital fund supporting spin-offs/startups valorizing research from knowledge partners. (Qbic)
- Their news shows active pre-seed/seed investments in 2025 (e.g., late 2025 pre-seed funding announcement). (Qbic)
- Qbic announced the first close of Qbic III at €49M (2022) and continues deploying from that vehicle. (Global Venturing)
Stage sweet spot: pre-seed/seed, especially when IP and academic roots are central.
Best fit if you are: university spin-out, deep tech, medtech, biotech tooling—anything where translation to market is the hard part.
How to pitch Qbic:
- Don't just pitch tech—pitch commercialization: who buys, why now, how adoption happens.
- Be crisp on IP ownership and freedom-to-operate.
7) Fund+ (Leuven) — Belgium-focused life sciences specialist
Why they're top-tier: Fund+ is one of Belgium's most recognizable life sciences investors with a stated focus on Belgium.
What they say they do:
- Fund+ describes itself as an open-ended fund for long-term equity investment in innovative life sciences companies, with a focus on Belgium. (fundplus.be)
Stage sweet spot: life sciences across stages (depends on opportunity), with a long-term orientation.
Best fit if you are: therapeutics, diagnostics, medtech platforms, biotech enabling tech with a strong scientific core.
How to pitch Fund+:
- Present a milestone-driven plan (preclinical → IND/clinical → partnering).
- Be very clear about capital needs and dilution strategy—life sciences is a multi-round journey.
8) V-Bio Ventures (Ghent) — Life sciences VC + co-creation
Why founders rate them: they combine investing with building/co-creating companies—great when you're spinning out science into a company.
What they're actively doing (signal):
- V-Bio states it co-creates startups and invests in early- to mid-stage life science companies. (v-bio.ventures)
- Global Venturing reported V-Bio finalized Fund 2 and had €185M under management at that time (2022), indicating meaningful platform scale for the region. (Global Venturing)
- They're still appearing in 2025 financing ecosystems (e.g., referenced as an existing investor in 2025 life-science funding announcements). (VIB Press)
Stage sweet spot: early → mid (biotech/medtech), especially spin-outs.
Best fit if you are: translational science teams that need "company formation + early financing + sector expertise."
How to pitch V-Bio:
- Make your "science to product" narrative brutally concrete.
- Show you understand regulatory path, clinical adoption, and how value is created (data, IP, trials, partnerships).
3) 5 quick tips to pitch Belgian VCs (and get to "yes" faster)
-
Lead with the wedge. Belgian investors (especially B2B and deep tech) respond to crisp specificity, not vague ambition.
-
Use a Belgium-native proof point. If you have ties to imec/universities/hospitals/industry clusters—make it a strength, not a footnote.
-
Show fundable milestones. Define the next 12–18 months as 2–3 milestones with a clear budget and measurable outcomes.
-
Make your round easy to syndicate. Local funds often co-invest. A clean story + clean materials increases the odds they'll pull in strong co-investors.
-
Be ready for diligence hygiene. Cap table clarity, IP assignment, security posture (for B2B), regulatory stance (for health), and metrics definitions—have them ready. Use a professional data room like Peony to organize materials with AI-powered organization and track investor engagement with page-level analytics.
Why professional data rooms matter for Belgium fundraising
Belgium startups need to present complex documentation—financial projections, product demos, team bios, and validation data—professionally to build investor confidence.
Peony helps Belgium startups create investor-ready data rooms with AI-powered organization that sets up in minutes instead of weeks.
Key benefits: page-level analytics show which documents investors review most, enterprise security protects sensitive information, and transparent pricing at $40/user/month—93-99% cheaper than legacy platforms charging $5,000-20,000 per deal.
Conclusion
Raising capital in Belgium in 2025 requires matching your stage, sector, and ecosystem path to the right investors. The investors on this list are actively deploying, but they're selective. Bring crisp wedges, fundable milestones, and a clean data room—not just vision.
Having a professional data room is table stakes for serious fundraising. Peony helps Belgium startups organize investor materials, track engagement, and securely share sensitive data at a fraction of legacy platform costs.
Ready to pitch Belgian investors? Set up your investor data room with Peony in minutes, not weeks.
Q&A Section
What's the best way to organize investor materials for Belgium fundraising?
Peony offers AI-powered document organization that automatically structures financials, product demos, team bios, and validation data into a professional data room in minutes. Page-level analytics show which documents investors review most, helping you anticipate questions.
How can I track which investors are most engaged with my Belgium startup pitch?
Peony provides page-level analytics showing which documents investors review and how much time they spend on each section. This helps identify serious investors and tailor follow-up conversations with actionable insights.
What's the most cost-effective data room solution for Belgium startups raising capital?
Peony offers transparent pricing at $40/user/month—93-99% cheaper than legacy platforms charging $5,000-20,000 per deal. For a 5-person team, Peony costs $200/month vs $3,000-5,000+ for legacy platforms, delivering enterprise features at startup-friendly pricing.
How do I securely share sensitive financial and operational information with Belgian investors?
Peony provides enterprise-grade security with identity-bound access, dynamic watermarking, and screenshot protection. With link expiry and instant access revocation, you maintain complete control over sensitive documentation.
What data room features are essential for Belgium startups pitching to investors?
Belgium startups need data rooms that handle complex documentation: financials, product demos, team bios, and validation data. Peony offers AI-powered organization, page-level analytics, custom branding, and comprehensive security. With 10-minute setup vs weeks for legacy platforms, Peony helps Belgium startups look professional without breaking the budget.
Related Resources
- Belgium Series A Investors: Complete Guide to Getting Funded in 2025
- Why Startups Need Data Rooms for Fundraising Success
- How Data Rooms Give Startups a Competitive Edge in Fundraising
- Best Data Rooms for Startups in 2025
- What Makes a Data Room Investor Ready
- Startup Fundraising Strategy in 2025: Complete Guide
- How to Send Pitch Deck to Investors in 2025
- The Rise of AI-Powered Data Rooms in 2025
- Fundraising Data Rooms
- Startup Data Rooms

